StreetInsider.com News Articles

Form 4 OCULAR THERAPEUTIX, INC For: Aug 24 Filed by: Kaiser Peter

Wed, 26 Aug 2026 18:00:00 -0400

si-local-file:///var/storage/secattach/20260826/26983051.html

Form 4 OCULAR THERAPEUTIX, INC For: Aug 24 Filed by: Kaiser Peter

Wed, 26 Aug 2026 18:00:00 -0400

si-local-file:///var/storage/secattach/20260826/26983051.html

Form 4 OCULAR THERAPEUTIX, INC For: Aug 24 Filed by: Nayak Sanjay

Wed, 26 Aug 2026 17:58:00 -0400

si-local-file:///var/storage/secattach/20260826/26983048.html

Form 4 OCULAR THERAPEUTIX, INC For: Aug 24 Filed by: Nayak Sanjay

Wed, 26 Aug 2026 17:58:00 -0400

si-local-file:///var/storage/secattach/20260826/26983048.html

Form 4 OCULAR THERAPEUTIX, INC For: Aug 24 Filed by: Heier Jeffrey S.

Wed, 26 Aug 2026 17:57:00 -0400

si-local-file:///var/storage/secattach/20260826/26983046.html

Form 4 OCULAR THERAPEUTIX, INC For: Aug 24 Filed by: Heier Jeffrey S.

Wed, 26 Aug 2026 17:57:00 -0400

si-local-file:///var/storage/secattach/20260826/26983046.html

Form 4 OCULAR THERAPEUTIX, INC For: Aug 24 Filed by: Dugel Pravin

Wed, 26 Aug 2026 17:56:00 -0400

si-local-file:///var/storage/secattach/20260826/26983043.html

Form 4 OCULAR THERAPEUTIX, INC For: Aug 24 Filed by: Dugel Pravin

Wed, 26 Aug 2026 17:56:00 -0400

si-local-file:///var/storage/secattach/20260826/26983043.html

Form 144 OCULAR THERAPEUTIX, INC Filed by: Nayak Sanjay

Mon, 24 Aug 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260824/26968743.html

Form 144 OCULAR THERAPEUTIX, INC Filed by: Nayak Sanjay

Mon, 24 Aug 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260824/26968743.html

Form 144 OCULAR THERAPEUTIX, INC Filed by: Dugel Pravin

Mon, 24 Aug 2026 16:45:00 -0400

si-local-file:///var/storage/secattach/20260824/26968731.html

Form 144 OCULAR THERAPEUTIX, INC Filed by: Dugel Pravin

Mon, 24 Aug 2026 16:45:00 -0400

si-local-file:///var/storage/secattach/20260824/26968731.html

Form 144 OCULAR THERAPEUTIX, INC Filed by: Heier Jeffrey S.

Mon, 24 Aug 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260824/26968722.html

Form 144 OCULAR THERAPEUTIX, INC Filed by: Heier Jeffrey S.

Mon, 24 Aug 2026 16:44:00 -0400

si-local-file:///var/storage/secattach/20260824/26968722.html

Form 144 OCULAR THERAPEUTIX, INC Filed by: Kaiser Peter

Mon, 24 Aug 2026 16:43:00 -0400

si-local-file:///var/storage/secattach/20260824/26968710.html

Form 144 OCULAR THERAPEUTIX, INC Filed by: Kaiser Peter

Mon, 24 Aug 2026 16:43:00 -0400

si-local-file:///var/storage/secattach/20260824/26968710.html

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Thu, 13 Aug 2026 16:05:00 -0400

BEDFORD, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to Ms. Beth Rada, the Company’s new SVP, Government Affairs and Public Policy. The awards were made as an inducement material to the recipient’s acceptance of employment with Ocular under Ocular’s 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).

The inducement equity awards granted to Ms. Rada were effective as of August 10, 2026 and consist of a

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Thu, 13 Aug 2026 16:05:00 -0400

The inducement equity awards granted to Ms. Rada were effective as of August 10, 2026 and consist of a

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Thu, 13 Aug 2026 16:05:00 -0400

The inducement equity awards granted to Ms. Rada were effective as of August 10, 2026 and consist of a

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Thu, 13 Aug 2026 16:05:00 -0400

The inducement equity awards granted to Ms. Rada were effective as of August 10, 2026 and consist of a

Increasing unusual put volume: OCUL IRM ALOY DFTX WY CIA ATAI WGMI ROST SLS EQX CRWG MUU CAVA BURL D NBIG ZSL

Wed, 12 Aug 2026 10:09:03 -0400

Increasing unusual put volume: OCUL IRM ALOY DFTX WY CIA ATAI WGMI ROST SLS EQX CRWG MUU CAVA BURL D NBIG ZSL

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fri, 07 Aug 2026 16:05:00 -0400

BEDFORD, Mass., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement equity awards to eight newly hired non-executive employees. The awards were made as an inducement material to each recipient’s acceptance of employment with Ocular under Ocular’s 2019 Inducement Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).

The inducement equity awards were granted effective as of August 3, 2026, and consist of non-statutory stock option awards to purchase up to an aggregate

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fri, 07 Aug 2026 16:05:00 -0400

The inducement equity awards were granted effective as of August 3, 2026, and consist of non-statutory stock option awards to purchase up to an aggregate

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fri, 07 Aug 2026 16:05:00 -0400

The inducement equity awards were granted effective as of August 3, 2026, and consist of non-statutory stock option awards to purchase up to an aggregate

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fri, 07 Aug 2026 16:05:00 -0400

The inducement equity awards were granted effective as of August 3, 2026, and consist of non-statutory stock option awards to purchase up to an aggregate